Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). The Cooper's share price for the quarter that ended in Jan. 2024 was $93.2575. The Cooper's Shares Outstanding (EOP) for the quarter that ended in Jan. 2024 was 199 Mil. Therefore, The Cooper's market cap for the quarter that ended in Jan. 2024 was $18,530 Mil.
The Cooper's quarterly market cap
declined
from Jul. 2023 ($19,367 Mil) to Oct. 2023 ($15,439 Mil) but then
increased
from Oct. 2023 ($15,439 Mil) to Jan. 2024 ($18,530 Mil).
The Cooper's annual market cap
declined
from Oct. 2021 ($20,554 Mil) to Oct. 2022 ($13,478 Mil) but then
increased
from Oct. 2022 ($13,478 Mil) to Oct. 2023 ($15,439 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. The Cooper's Enterprise Value for Today is $20,295 Mil.
The Cooper Market Cap Historical Data
The historical data trend for The Cooper's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, The Cooper's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cooper's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Market Cap distribution charts can be found below:
* The bar in red indicates where The Cooper's Market Cap falls into.
The Cooper Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
The Cooper's Market Cap for the fiscal year that ended in Oct. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Cooper (NAS:COO) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
The Cooper Market Cap Related Terms
Thank you for viewing the detailed overview of The Cooper's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
COO has been successfully added to your 